Interaction of a blood coagulation factor on electrically polarized hydroxyapatite surfaces

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 82, Issue 1, 2007, Pages 29-36

  Nakamura, Miho ^a   Niwa, Kazuki ^b   Nakamura, Satoshi ^a   Sekijima, Yasutaka ^a   Yamashita, Kimihiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Blood material interaction; Coagulation factors; Hydroxyapatite; Interface; Plasma protein

Indexed keywords

BLOOD-MATERIAL INTERACTION; COAGULATION FACTORS; FIBRIN; OSTEOCONDUCTIVITY;

BLOOD; COAGULATION; POLARIZATION; PROTEINS; TISSUE;

HYDROXYAPATITE;

ALPHA POLYMER; ANION; BIOMATERIAL; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; BUFFER; CALCIUM ION; CATION; DIMER; FIBRIN; GAMMA CHAIN; GAMMA DIMER; HYDROXYAPATITE; PLASMA PROTEIN; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; BONE CONDUCTION; CALCIUM TRANSPORT; CATALYSIS; CELL FUNCTION; CHARGE NURSE; ELECTRICAL POLARIZATION; ENZYME ACTIVATION; INCUBATION TIME; MASS SPECTROMETRY; OSSIFICATION; POLARIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN INTERACTION; PROTEIN STABILITY; SURFACE CHARGE; SURFACE PROPERTY;

BONE SUBSTITUTES; CALCIUM; CERAMICS; DURAPATITE; ELECTRICITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR XIII; HUMANS; OSTEOGENESIS; SURFACE PROPERTIES;

EID: 34347334437     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30701     Document Type: Article

References (50)

1. Yamashita K, Oikawa N, Umegaki T. Acceleration and deceleration of bone-like crystal growth on ceramic hydroxyapatite by electric poling. Chem Mater 1996;8:2697-2700.
2. Yamashita K, Nakamura S. Concept and development of vector ceramics for bio-interface engineering. J Ceram Soc Jpn 2005;113:1-9.
3. Kobayashi T, Nakamura S, Yamashita K. Enhanced osteobonding by negative surface charges of electrically polarized hydroxyapatite. J Biomed Mater Res 2001;57:477-484.
4. Nakamura S, Kobayashi T, Yamashita K. Numerical osteobonding evaluation of electrically polarized hydroxyapatite ceramics. J Biomed Mater Res A 2004;68;90-94.
5. Itoh S, Nakamura S, Kobayashi T, Shinomiya K, Yamashita K. Effect of electrical polarization of hydroxyapatite ceramics on new bone formation. Calcif Tissue Int 2006;78:133-142.
6. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
7. Schwartz Z, Boyan BD. Underlying mechanisms at the bone-biomaterial interface. J Cell Biochem 1994;56:340-347.
8. Behling CA, Spector M. Quantitative characterization of cells at the interface of long-term implants of selected polymers. J Biomed Mater Res 1986;20:653-666.
9. Christenson L, Aebischer P, McMillan P, Galletti PM. Tissue reaction to intraperitoneal polymer implants: Species difference and effects of corticoids and doxorubicin. J Biomed Mater Res 1989;23:705-718.
10. Kottke-Marchant K, Anderson JM, Rabinovitch A. The platelet reactivity of vascular graft prostheses. Biomaterials 1986;7:441-448.
11. Kottke-Marchant K, Anderson JM, Umemura Y, Marchant RE. Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. Biomaterials 1989;10:147-155.
12. Marchant RE, Miller KM, Anderson JM. In vivo biocompatibility studies. V. In vivo leukocyte interactions with Biomer. J Biomed Mater Res 1984;18:1169-1190.
13. Gordon M, Bullough PG. Synovial and osseous inflammation in failed silicone-rubber prostheses. J Bone Joint Surg Am 1982;64:574-580.
14. Kossovsky N, Millett D, Juma S, Little N, Briggs PC, Raz S, Berg E. In vivo characterization of the inflammatory properties of poly(tetrafluoroethylene) particulates. J Biomed Mater Res 1991;25:1287-1301.
15. Colman RW. Surface-mediated defense reactions: The plasma contact activation system. J Clin Invest 1984;73:1249-1253.
16. Yates SG II, Nakagawa Y, Berger K, Sauvage LR. Surface thrombogenicity of arterial prostheses. Surg Gynecol Obstet 1973;136:12-16.
17. Gobel RJ, Janatova J, Googe JM, Apple DJ. Activation of complement in human serum by some synthetic polymers used for intraocular lensed. Biomaterials 1987;8:285-288.
18. Kottke-Marchant K, Anderson JM, Miller KM, Marchant RE, Lazarus H. Vascular graft-associated complement activation and leukocyte adhesion in an artificial circulation. J Biomed Mater Res 1987;21:379-397.
19. Nusbacher J, Rosefeld SI, MacPherson JL, Thiem PA, Leddyu JP. Nylon fiber leukapheresis: Associated complement component changes and cranulocytopenia. Blood 1978;51:359-365.
20. Hogt AH, Dankert J, Feijen J. Adhesion of coagulase-negative staphylococci to methacrylate polymers and copolymers. J Biomed Mater Res 1986;20:533-545.
21. Nakamura M, Nakamura S, Sekijima Y, Niwa K, Kobayashi T, Yamashita K. The role of blood coagulation components as intermediators of high osteoconductivity of electrically polarized hydroxyapatite. J Biomed Mater Res, in press.
22. Schwartz ML, Pizzo SV, Hill RL, Mckee PA. Human factor XIII rom plasma and platelets. J Biol Chem 1973;248:1395-1407.
23. Folk JE, Finlayson JS. The ε-(γ-glutamyl) lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 1977;31:1-132.
24. Takagi T, Iwanaga S. Isolation and characterization of the polypeptide chain involved in the cross-linking of stabilized bovine fibrin. J Biochem 1971;69:699-709.
25. Kienapfel H, Swain R, Hettel A, Wilke A, Koller M, Griss P. Recombinant and nonrecombinant factor XIII and its effect on bone ingrowth and strength of fixation. Arch Orthop Trauma Surg 1997;116:239-243.
26. Gerngross H, Burri C, Claes L. Experimental studies on the influence of fibrin adhesive, factor XIII, and calcitonin on the incorporation and remodeling of autologous bone grafts. Arch Orthop Trauma Surg 1986;106:23-31.
27. Hornyak TJ, Shafer JA. Role of calcium ion in the generation of factor XIII activity. Biochemistry 1991;30:6175-6182.
28. Nakamura S, Kobayashi T, Yamashita K. Extended bioactivity in the proximity of hydroxyapatite ceramic surfaces induced by polarization charges. J Biomed Mater Res 2002;61:593-599.
29. Nakamura S, Takeda H, Yamashita K. Proton transport polarization and depolarization of hydroxyapatite ceramics. J Appl Phys 2001;89:5386-5392.
30. Niwa K, Takebe M, Suga T, Kawata Y, Mimura J, Asakura S, Sakata Y, Mizushima J, Maeda A, Endo H, Matsuda M. A γ Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I. Blood 1996;87:4686-4694.
31. Lorand L. Factor XIII: Structure, activation, and interaction with fibrinogen and fibrin. Ann NY Acad Sci 2001;936:291-311.
32. Takagi T, Doolittle RF. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 1974;13:750-756.
33. Nakamura S, Iwanaga S, Suzuki T. On the activation of bovine plasma factor XIII-amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides. J Biochem 1975;78:1247-1266.
34. Wolfenstein-Todel C, Mosesspm MW. Human plasma fibrinogen heterogeneity: Evidence for an extended carboxyl-terminal sequence in a normal γ chain variant (γ′). Proc Natl Acad Sci USA 1980;77:5069-5073.
35. Curtis CG, Brown KL, Credo RB, Domanik RA, Gray A, Stenberg P, Lorand L. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry 1974;13:3774-3780.
36. Ducheyne P, Radin S, King L. The effect of calcium phosphate ceramic composition and structure on in vitro behavior. I. Dissolution. J Biomed Mater Res 1993;27:25-34.
37. Fulmer MT, Ison IC, Hankermayer CR, Constantz BR, Ross J. Measurements of the solubilities and dissolution rates of several hydroxyapatites. Biomaterials 2002;23:751-755.
38. Hench LL, Wilson J. Introduction to Bioceramics. Singapore: World Scientific; 1993. p 159.
39. Lorand L. Activation of blood coagulation factor XIII. Ann NY Acad Sci 1986;485:144-158.
40. 2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII. Ann NY Acad Sci 1986;485:134-139.
41. Arnold U, Schweitzer S, Lindenhayn K, Perka C. Optimization of bone engineering by means of growth factors in a three-dimensional matrix. J Biomed Mater Res A 2003;67:260-269.
42. Weiss E, Yamaguchi Y, Falabella A, Crane S, Tokuda Y, Falanga V. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: Correction with fibronectin and factor XIII cross-linking. J Cell Phys 1998;173:58-65.
43. Kilian O, Fuhrmann R, Alt V, Noll T, Coskun S, Dingeldein E, Schnettler R, Franke RP. Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats. Biomaterials 2005;26:1819-1827.
44. Hu WJ, Eaton JW, Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001;98:1231-1238.
45. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003;24:2497-2502.
46. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;1:93-103.
47. Oprea WE, Karp JM, Hosseini MM, Davies JE. Effect of platelet releasate on bone cell migration and recruitment in vitro. J Craniofac Surg 2003;14:292-300.
48. Barry ELR, Mosher DF. Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. J Biol Chem 1988;263:10464-10469.
49. Mosher DF. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 1975;250:6614-6621.
50. Okada M, Blomback B, Chang MD, Horowitz B. Fibronectin and fibrin gel structure. J Biol Chem 1985;260:1811-1820.